Keywords
Endometriosis; Kallistatin; follicular uid; IVF outcome
Posted Date: January 9th, 2021
DOI: https://doi.org/10.21203/rs.3.rs-140378/v1
License: This work is licensed under a Creative Commons Attribution 4.0 International License.
Read Full License
Version of Record: A version of this preprint was published at Gynecological Endocrinology on July 8th,
2021. See the published version at https://doi.org/10.1080/09513590.2021.1928067.
Page 2/11
Abstract
Background: Endometriosis (EM) affects 10% of women in reproductive age and alters fertility. Its
management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an
endogenous protein that regulates differential signaling pathways and biological functions. However, the
function and the underlying molecular mechanism in endometriosis and its correlation with IVF outcome
have not been determined. The purpose of this study was to evaluate KS concentrations in follicular uid
of women with EM and controls women without EM who underwent IVF with embryo transfer (IVF–ET).
Methods
Follicular uid KS concentrations from 40 patients with EM and 40 non-EM patients were
measured by ELISA.
Results
Compared with the non-EM patients, patients with EM had lower KS levels in follicular uid
(281.67±104.60 pg/ml vs. 490.70 ±216.33pg/ml). The rates of fertilization(61.64±22.42% vs.
71.00±24.39%) , available embryo (45.96±19.83% vs.50.61±26.26%) and top-quality
embryo(12.71±21.01% vs.16.04±16.87%) were signicantly lower in the EM group than in the control
group. The KS concentrations in the follicular uid of women who conceived consequent to the treatment
were signicantly higher than those from women who did not in the combined EM and control groups.
Conclusions
The present results indicate that the KS concentration in follicular uid could be used as a predictor for
IVF–ET outcomes. This may contribute to the pathologic mechanism responsible for the poor outcome of
IVF in patients with EM.
Background
Endometriosis is a common chronic gynecologic disorder dened by the ectopic occurrence of
endometrium-like tissue which is associated with pelvic pain and infertility[1]. It has been estimated at
10% in women of reproductive age[2]. The causes of infertility in women with endometriosis may range
from anatomical distortions due to adhesions and brosis to abnormalities and immunological
disturbances[3, 4]. Approximately 25–50% of infertile women have EM, and 30–50% of women with EM
are infertile[5]. Assisted reproductive technology (ART) may be required with endometriosis-related
infertility. Accumulating evidence suggests that EM affects oocyte and embryo development as well as
endometrial receptivity, resulting in poor in vitro fertilization (IVF) outcomes[6-10]. However, the
mechanism is unclear.
Follicular fuid (FF) provides an environment that controls oocyte growth and maturation, and plays a key
role in ovulation, subsequent fertilization and early embryo development[11]. Both cellular and secreted
mediators are aberrantly expressed in the peritoneal fuid (PF) and plasma of EM patients[12]. Some
studies have shown that angiogenesis and tissue growth factor are increased in the serum and PF of
women with EM[13, 14].
Page 3/11
For these reasons, we analyzed the concentrations of KS in the FF of women undergoing IVF to identify
factors related to EM and to further elucidate its correlation with IVF outcome. KS is an endogenous
protein that regulates differential signaling pathways and biological functions inhibiting inammation,
angiogenesis, oxidative stress, apoptosis, tumor growth and metastasis in animal models and cultured
cells[15-22]. Plasma levels of KS are reduced in patients with sepsis, liver disease and obesity[23, 24]. Our
preliminary data showed that KS in EM patients’ endometrial tissue and blood were much lower than
control patients without endometriosis and the decrease of KS is correlated with the severity of
endometriosis. However, the concentrations of KS in the follicular uid of EM patients and its correlation
with IVF outcome have not been determined.
The aim of this study was to investigate KS in follicular uid of women with endometriosis and its
correlation with IVF outcome. This information may form the basis of strategies to control these factors
and improve the IVF outcomes in patients with EM.
Methods
Subjects
A total of 80 patients who underwent IVF-ET between July 2017 and August 2018 in the Center for
Reproductive Medicine, Third Aliated Hospital of Guangzhou Medical University, were recruited for this
study. The study population consisted of Forty women with EM and 40 women without EM. The presence
or absence of endometriosis was con fi rmed by laparoscopic surgery and post-operative histological
examination. Women with polycystic ovary syndrome, diabetes, hypertension, dyslipidemia, HIV infection
or any active infection and autoimmune diseases were excluded. Follicular uid (FF) was extracted from
both groups.
ART procedures
Women were monitored and managed according to the hospital’s clinical protocols. Various controlled
ovarian stimulation (COS) protocols were used, with 150-450 IU/day of recombinant FSH or human
menopausal gonadotropin in a gonadotropin-releasing hormone antagonist protocol, a long agonist
protocol, or a short agonist protocol. The protocols were determined according to each patient's
characteristics (age, body mass index (BMI), AFC and AMH). Transvaginal oocyte retrieval was scheduled
35-36 h after hCG injection ART was performed per standard operating procedure of the hospital.
Fertilization was assessed by the appearance of two pronuclei. Cleavage stage embryos were graded as
per the Istanbul consensus. Fresh embryo transfer (ET) was performed 2-3 or 5 days later. Embryos were
vitried frozen on day 3,5 or 6. The luteal phase was supported by vaginal administration of micronized
progesterone (400 mg/d) started on the day of ovarian puncture.
Follicular uid collection
Page 4/11
Follicular uid was preserved at oocyte retrieval, by collecting the liquid aspirated from the follicle into the
suction tube, to avoid contamination by blood. Follicular uid samples from each follicle were pooled for
each patient for measurement of KS concentrations. Pooled follicular uid was centrifuged at 1500g for
10 min to eliminate cells and cell debris. And the supernatants were then stored at -20°C for KS
concentration measurements.
KS and hormone assays
The follicular uid KS concentrations were collected and determined measured by enzyme-linked
immunosorbent assay (human kallistatin ELISA kits, Catalog Number: DY1669; R&D Systems, USA)
according to the manufacturer's protocol. The concentrations of serum oestradiol, FSH, LH, progesterone,
testosterone and AMH, and follicular uid oestradiol and progesterone, were measured by
chemiluminescence (Roche, Switzerland).
Outcome measure
The reproductive outcome of this study included implantation, clinical pregnancy, live birth rate (LBR) and
spontaneous miscarriage rates. Neonatal outcomes included preterm birth, stillbirth, birth weight, low
birth weight and congenital anomalies. Live birth was dened as the delivery of any viable neonate who
was 28 weeks of gestation or older, and twins delivered by one mother were calculated as one live birth.
Clinical pregnancy was dened as the present of gestational sac on ultrasound at 6-8 weeks of gestation;
low birth weight was dened as the birth weight less than 2500 g and very low birth weight less than
1500 g.
Statistical analysis
The statistical analysis was performed using the Statistical Package for Social Science (SPSS) version
22.0. The baseline characteristic was expressed as the mean ± SD (standard deviation) and differences
in variables were compared by means of Student’s t-test. Categorical variables were described as
frequencies and percentages, and compared using chi-square test. A P-value of 0.05 was considered
signicant.
Results
Patient characteristics
Eighty women were selected. Baseline characteristics of these women are shown in Table 1. No
signicant differences were observed between the EM and control groups regarding age, body mass
index and duration of sterility. In the control group, there were 4 patients with infertility due to tubal factor
(10%), two cases of ovulatory dysfunction (5%), 20 cases of male factor (50%), 14 cases of unexplained
(35%).30 patients in the control group were given IVF protocols, while 10 underwent ICSI procedures. In
EM group, IVF protocols were given to 70% women and 30% underwent ICSI procedures.
Page 5/11
KS expression was decreased in FF of EM patients
Serum concentration of base LH, FSH, Progesterone(P), Testosterone(T), E2 and AMH showed no
difference between the EM and control groups. Moreover, The FF KS concentrations in the EM patients
were 281.67±104.60 pg/ml and lower than those in the control group (490.70 ±216.33pg/ml) (P < 0.05)
(Table 2).
ART Cycle Characteristics in EM and control subjects.
Comparisons of ART Cycle Characteristics between the EM and control groups were summarized in Table
3. The AFC, Dosage of Gn, Endometrial thickness, No. of embryos retrieved, the rates of cleavage and No.
of embryos transferred were similar among between the two FET groups. Meanwhile, the rates of
fertilization, available embryo and top-quality embryo were signicantly lower in the EM group than in the
control group.
KS concentrations in follicular uid from subjects with different pregnancy outcomes
The clinical pregnancy rate in the EM group was 61.54% (24/39), which was signicantly lower than that
in the control group (67.57%, 25/37). In both the EM (Figure 1B) and control groups (Figure 1A), the KS
concentrations in the follicular uid of women who conceived consequent to the treatment were
signicantly higher than those in women who did not. The KS concentrations in the follicular uid of
women who conceived consequent to the treatment were signicantly higher than those from women
who did not in the combined EM and control groups (P < 0.05; Figure 1C). To evaluate the potential of KS
concentrations in the follicular uid for predicting clinical pregnancy, receiver operating characteristic
(ROC) curves were plotted, and the area under the curve (AUC) values were determined with the highest
specicity and sensitivity set as the optimal prediction point (Figure 1D). Optimal prediction point,
sensitivities, specicities and AUC values were 292.78 pg/ml, 71.7%, 65% and 0.7279, respectively. The
present results indicate that the KS concentration in follicular uid could be used as a predictor for IVF–
ET outcomes.
Discussion
FF composition is complex and is basically derived from plasma exudation and ovarian secretion[25]. It
is an important environment for oocyte survival and directly affects oocyte maturation and quality. FF
contains a large number of cytokines, a variety of hormones, oxidation/ antioxidant systems and
metabolic products [13].
In this study, analysis of the levels of KS in follicular uid of women with EM and controls women without
EM who underwent IVF with embryo transfer (IVF–ET). Data clearly show thatcompared with the non-EM
patients, patients with EM had lower KS levels in follicular uid. This indicates that low KS concentrations
in follicular uid may play a key role in folliculogenesis and the pathogenesis of EM. However, there were
no differences in the concentrations of LH FSH P T E2 and AMH between the EM and control groups.
Page 6/11
This means that the KS changes of follicular microenvironment caused by EM are independent of these
six factors.
KS is an endogenous protein that regulates differential signaling pathways and biological functions. Our
preliminary data showed that KS in EM patients’ endometrial tissue and blood were much lower than
control patients without endometriosis and the decrease of KS is correlated with the severity of
endometriosis. However, the concentrations of KS in the follicular uid of EM patients and its correlation
with IVF outcome have not been determined. This study found that the rates of fertilization, available
embryo and top-quality embryo were signicantly lower in the EM group than in the control group. This
Result
is consistent with the worse prognosis of EM reported in previous literature. We supposed that KS
can signicantly improve the quality of oocytes and embryos.
However, whether KS can act as a biomarker for predicting the clinical pregnancy of EM remain unknown.
ROC curves were plotted in our study, result showed that the area under the curve (AUC) values was
0.7279. The present results indicate that the KS concentration in follicular uid could be used as a
predictor for IVF–ET outcomes.
Based on the ndings of our study, we conclude that KS is associated with the microenvironment of FF in
patients with EM. The change in the regulation network in EM inuence oocyte development, resulting in
poor IVF outcomes. However, the results in this study should be validated in a large sample in the future.
Conclusion
Our study provides a theoretical basis for the development of strategies to improve the outcome of IVF in
patients with EM. This evidence may help to clarify the pathology of EM and seek new treatments for EM
patients.
Abbreviations
Endometriosis EM
Kallistatin KS
in vitro fertilization IVF
peritoneal fuid PF
Follicular fuid FF
controlled ovarian stimulation COS
body mass index BMI
live birth rate LBR
Page 7/11
area under the curve AUC
luteinizing hormone LH
Follicle-Stimulating Hormone FSH
progesterone P
testosterone T
estrogen E2
Anti-mullerian hormone AMH
Declarations
Ethical Approval and Consent to participate
This study was approved by the ethics committee of the Third Aliated Hospital of Guangzhou Medical
University.
Consent for publication
Not applicable.
Availability of supporting data
The data sets used and/or analyzed during the current study are available from the corresponding author
on reasonable request.
Competing interests
The authors have declared that no conict of interest exists.
Funding
This study was supported by National Nature Science Foundation of China, Grant Numbers: 81871211
Authors' contributions
All authors have contributed signicantly to this manuscript and each author has contributed to the
manuscript as follows: Yuling Mao and Rui Chen designed the project. Yuling Mao, Shaoquan Zhan
collected clinical samples and performed the ELISA experiments. Jingda Qiao and Lei Li analyzed the
data. Yuling Mao wrote the manuscript. Hanyan Liu and Rui Chen revised the manuscript. All authors
Page 8/11
read and approved the nal manuscript.
Acknowledgements
The study was performed under the auspices of the IVF unit of the Third Aliated Hospital of Guangzhou
Medical University.
References
1. Gordts S, Koninckx P, Brosens I. Pathogenesis of deep endometriosis. Fertil Steril. 2017;108(6):872–
85 e1.
2. Meuleman C, et al. High prevalence of endometriosis in infertile women with normal ovulation and
normospermic partners. Fertil Steril. 2009;92(1):68–74.
3. Senapati S, et al. Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the
Society for Assisted Reproductive Technologies Database. Fertil Steril. 2016;106(1):164–71 e1.
4. Vercellini P, et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261–
75.
5. Du YB, et al. Endocrine and inammatory factors and endometriosis-associated infertility in assisted
reproduction techniques. Arch Gynecol Obstet. 2013;287(1):123–30.
. Da Broi MG, et al. Oocyte oxidative DNA damage may be involved in minimal/mild endometriosis-
related infertility. Mol Reprod Dev. 2018;85(2):128–36.
7. Garrido N, et al. The endometrium versus embryonic quality in endometriosis-related infertility. Hum
Reprod Update. 2002;8(1):95–103.
. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril.
2002;77(6):1148–55.
9. Freis A, et al. Relative Morphokinetics Assessed by Time-Lapse Imaging Are Altered in Embryos From
Patients With Endometriosis. Reprod Sci. 2018;25(8):1279–85.
10. Sanchez AM, et al., Is the oocyte quality affected by endometriosis? A review of the literature. Journal
of Ovarian Research, 2017. 10.
11. Da Broi MG, et al. Inuence of follicular uid and cumulus cells on oocyte quality: clinical
implications. J Assist Reprod Genet. 2018;35(5):735–51.
12. Miller JE, et al. Implications of immune dysfunction on endometriosis associated infertility.
Oncotarget. 2017;8(4):7138–47.
13. Taylor RN, Lebovic DI, Mueller MD, Angiogenic factors in endometriosis. Ann N Y Acad Sci, 2002.
955: p. 89–100; discussion 118, 396–406.
14. Deguchi M, et al. Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep.
2001;8(6):1317–9.
15. Chao J, et al. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body uids, blood cells,
and tissues in health and disease. J Lab Clin Med. 1996;127(6):612–20.
Page 9/11
1. Zhu H, et al. Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently
healthy African American adolescents. Metabolism. 2013;62(5):642–6.
17. Miao RQ, et al. Structural elements of kallistatin required for inhibition of angiogenesis. Am J Physiol
Cell Physiol. 2003;284(6):C1604-13.
1. Shen B, et al. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and
activation of Akt-eNOS signaling. Am J Physiol Heart Circ Physiol. 2010;299(5):H1419–27.
19. Shen B, et al. Salutary effect of kallistatin in salt-induced renal injury, inammation, and brosis via
antioxidative stress. Hypertension. 2008;51(5):1358–65.
20. Wang CR, et al. Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat
arthritis by inhibiting angiogenesis and inammation. Arthritis Rheum. 2005;52(4):1319–24.
21. Yin H, et al. Kallistatin inhibits vascular inammation by antagonizing tumor necrosis factor-alpha-
induced nuclear factor kappaB activation. Hypertension. 2010;56(2):260–7.
22. Shiau AL, et al. Inhibition of experimental lung metastasis by systemic lentiviral delivery of
kallistatin. BMC Cancer. 2010;10:245.
23. Gao L, et al. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial
infarction. Lab Invest. 2008;88(11):1157–66.
24. Miao RQ, et al. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood.
2002;100(9):3245–52.
25. Kollmann Z, et al. Gonadotrophin stimulation in IVF alters the immune cell prole in follicular uid
and the cytokine concentrations in follicular uid and serum. Hum Reprod. 2017;32(4):820–31.
Tables
Due to technical limitations, table 1 to 3 is only available as a download in the Supplemental Files
section.
Figures
Page 10/11
Figure 1
KS concentrations in women who conceived consequent to the treatment (Pregnancy) and women who
did not (Non-pregnancy). (A) KS concentrations in follicular uid of control women in women who
conceived consequent to the treatment and those who did not. (B) KS concentrations in follicular uid of
EM patients who conceived consequent to the treatment and those who did not. (C) KS concentrations in
follicular uid of all women who conceived consequent to the treatment and women who did not. (*P <
0.05). (D) ROC curve analysis to assess the predictive powers of clinical pregnancy.
Page 11/11
Supplementary Files
This is a list of supplementary les associated with this preprint. Click to download.
table1.jpg
table2.jpg
table3.jpg
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.